Browse by topic
Subscribe to our blog

Overcoming medication adherence barriers in oral anticancer meds

Over the past decade, treatment in a variety of cancers, particularly breast cancer, chronic myelogenous leukemia, and non-small cell lung cancer, has switched from intermittent intravenous therapy to self-administered targeted oral anticancer ...

AllazoHealth now offers AI optimized therapy initiation

AllazoHealth continues to lead in advancing the use of artificial intelligence in healthcare. Building on our success in medication adherence, we have expanded our implementation of AI to include therapy initiation. Barriers to therapy initiation

Specialty drugs: the challenge of therapy initiation

AllazoHealth’s VP, Business Development Dev Mukherjee recently answered questions about specialty medications and the challenges faced by pharmaceutical companies and specialty drug pharmacies in regards to therapy initiation. What challenges do ...